These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 36692903)

  • 1. Substance use policy and practice in the COVID-19 pandemic: Learning from early pandemic responses through internationally comparative field data.
    Aronowitz SV; Carroll JJ; Hansen H; Jauffret-Roustide M; Parker CM; Suhail-Sindhu S; Albizu-Garcia C; Alegria M; Arrendondo J; Baldacchino A; Bluthenthal R; Bourgois P; Burraway J; Chen JS; Ekhtiari H; Elkhoy H; Farhoudian A; Friedman J; Jordan A; Kato L; Knight K; Martinez C; McNeil R; Murray H; Namirembe S; Radfar R; Roe L; Sarang A; Scherz C; Tay Wee Teck J; Textor L; Thi Hai Oanh K
    Glob Public Health; 2022 Dec; 17(12):3654-3669. PubMed ID: 36692903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.
    Schofield J; Dumbrell J; Matheson C; Parkes T; Bancroft A
    BMC Public Health; 2022 Mar; 22(1):500. PubMed ID: 35287630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
    Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis.
    Mitra S; Bouck Z; Larney S; Zolopa C; Høj S; Minoyan N; Upham K; Rammohan I; Mok WY; Hayashi K; Milloy MJ; DeBeck K; Scheim A; Werb D
    Harm Reduct J; 2024 May; 21(1):94. PubMed ID: 38750575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.
    Rains A; York M; Bolinski R; Ezell J; Ouellet LJ; Jenkins WD; Pho MT
    Harm Reduct J; 2022 Nov; 19(1):128. PubMed ID: 36403075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-level influences on increased overdose risk behaviors during the COVID-19 pandemic among people who use drugs in Rhode Island: a qualitative investigation.
    Frueh L; Collins AB; Newman R; Barnett NP; Rich JD; Clark MA; Marshall BDL; Macmadu A
    Harm Reduct J; 2023 Feb; 20(1):14. PubMed ID: 36739417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Essential work, precarious labour: The need for safer and equitable harm reduction work in the era of COVID-19.
    Olding M; Barker A; McNeil R; Boyd J
    Int J Drug Policy; 2021 Apr; 90():103076. PubMed ID: 33321286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "We do it ourselves": strengths and opportunities for improving the practice of harm reduction.
    Claborn K; Samora J; McCormick K; Whittfield Q; Courtois F; Lozada K; Sledge D; Burwell A; Chavez S; Bailey J; Bailey C; Pederson CD; Zagorski C; Hill L; Conway FN; Steiker LH; Cance J; Potter J
    Harm Reduct J; 2023 Jun; 20(1):70. PubMed ID: 37296459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "You know, we can change the services to suit the circumstances of what is happening in the world": a rapid case study of the COVID-19 response across city centre homelessness and health services in Edinburgh, Scotland.
    Parkes T; Carver H; Masterton W; Falzon D; Dumbrell J; Grant S; Wilson I
    Harm Reduct J; 2021 Jun; 18(1):64. PubMed ID: 34118942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "We have to be uncomfortable and creative": Reflections on the impacts of the COVID-19 pandemic on overdose prevention, harm reduction & homelessness advocacy in Philadelphia.
    Aronowitz SV; Engel-Rebitzer E; Lowenstein M; Meisel Z; Anderson E; South E
    SSM Qual Res Health; 2021 Dec; 1():100013. PubMed ID: 34870265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How understanding and application of drug-related legal instruments affects harm reduction interventions in Cambodia: a qualitative study.
    Tuot S; Ngin C; Pal K; Sou S; Sawez G; Morgan P; Srey M; Chan T; Chhoun P; Golichenko O; Choub SC; Yi S
    Harm Reduct J; 2017 Jun; 14(1):39. PubMed ID: 28629463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs.
    Conway FN; Samora J; Brinkley K; Jeong H; Clinton N; Claborn KR
    Harm Reduct J; 2022 Jul; 19(1):72. PubMed ID: 35780109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada.
    Ali F; Russell C; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    Int J Drug Policy; 2021 Jul; 93():103237. PubMed ID: 33893026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of the COVID-19 pandemic on illicit drug supply, drug-related behaviour of people who use drugs and provision of drug related services in Georgia: results of a mixed methods prospective cohort study.
    Otiashvili D; Mgebrishvili T; Beselia A; Vardanashvili I; Dumchev K; Kiriazova T; Kirtadze I
    Harm Reduct J; 2022 Mar; 19(1):25. PubMed ID: 35264181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A qualitative study exploring the impact of the COVID-19 pandemic on People Who Inject Drugs (PWID) and drug service provision in the UK: PWID and service provider perspectives.
    May T; Dawes J; Fancourt D; Burton A
    Int J Drug Policy; 2022 Aug; 106():103752. PubMed ID: 35653821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons from the COVID-19 pandemic for substance misuse services: findings from a peer-led study.
    Holloway K; Murray S; Buhociu M; Arthur A; Molinaro R; Chicken S; Thomas E; Courtney S; Spencer A; Wood R; Rees R; Walder S; Stait J
    Harm Reduct J; 2022 Dec; 19(1):140. PubMed ID: 36503439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harm Reduction Services in Ottawa: The Culture of Drug Use.
    Haines M; O'Byrne P
    Res Theory Nurs Pract; 2020 May; 34(2):188-202. PubMed ID: 32457123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative examination of substance use service needs among people who use drugs (PWUD) with treatment and service experience in Ontario, Canada.
    Russell C; Ali F; Nafeh F; LeBlanc S; Imtiaz S; Elton-Marshall T; Rehm J
    BMC Public Health; 2021 Nov; 21(1):2021. PubMed ID: 34742267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.